The latter is a particularly timely issue given that polymorphisms of patatin-like phospholipase domain-containing protein-3 (PNPLA3), a gene that controls hepatic NEFA content, is the strongest genetic association with bad NASH outcomes (i.e., cirrhosis and liver cancer) in humans [44]. This evidence concerns the gene PNPLA3 and Cirrhosis.